Liver biopsy: blind or guided?

BMJ 1994; 309 doi: http://dx.doi.org/10.1136/bmj.309.6967.1455 (Published 3 December 1994)
Cite this as: BMJ 1994;309:1455

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Guy Vautier,
  2. Brian Scott,
  3. David Jenkins

    Benefits of guided biopsy are clear only for focal lesions

    Despite advances in imaging techniques and serological investigations percutaneous needle biopsy of the liver is still important in accurately diagnosing hepatic disease. The basic technique, described by Sherlock, has changed little over the past 50 years.1 It is simple, cheap, and relatively safe and can be carried out at the bedside. In the past few years, however, ultrasonography has been increasingly used to guide the biopsy needle. A recent large survey of consultant gastroenterologists showed that 1 in 8 always used ultrasonography guidance for biopsies.2 Some consultants now believe that ultrasonographically guided biopsies are so much safer that blind biopsy can no longer be defended. Before this policy is adopted uncritically, however, it is important to examine the current evidence concerning safety, diagnostic yield, and cost.

    Percutaneous liver biopsy has a mortality of 0.01%-0.1%.3 4 Death is usually due to bleeding or to biliary peritonitis as a result of puncture from the gall bladder. The incidence …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL